{
    "id": "9132879",
    "text": "Elsilimomab (also known as B-E8) is a mouse monoclonal antibody and an immunosuppressive drug. B-E8 was developed by Diaclone, a French company which produces many mouse monoclonal antibodies. It (OPR-003) targets (and blocks) Interleukin-6. It has undergone a number of early stage clinical trails, e.g. for lymphoma and myeloma. It was used as a template to develop a high- affinity, antagonist, fully human anti-IL-6 mAb 1339. == References == Category:Monoclonal antibodies ",
    "title": "Elsilimomab"
}